| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Baird analyst David Rescott maintains Boston Scientific (NYSE:BSX) with a Outperform and raises the price target from $79 to...
Needham analyst Mike Cikos reiterates ServiceNow (NYSE:NOW) with a Buy and maintains $900 price target.
Baird analyst Jeff Johnson maintains Align Tech (NASDAQ:ALGN) with a Outperform and raises the price target from $333 to $370.
Baird analyst Michael Bellisario maintains Hilton Worldwide Holdings (NYSE:HLT) with a Outperform and raises the price targe...
The Company does not anticipate receipt of any additional milestone payments from collaborations in the remainder of 2024. The ...
Textron (NYSE:TXT) reported quarterly earnings of $1.20 per share which missed the analyst consensus estimate of $1.23 by 2.44 ...
HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Processa Pharma (NASDAQ:PCSA) with a Buy rating and...
